PRINCETON, N.J., March 10, 2005 (PRIMEZONE) -- The Bull Market Report (http://www.bullmarket.com), a long-term growth and income-generating focused investment newsletter, announced today that it has provided to trial and paid subscribers analysis of healthcare related stocks, including coverage of Invitrogen (NASDAQ:IVGN), Pfizer (NYSE:PFE), Sunrise Senior Living (NYSE:SRZ) and UnitedHealth Group (NYSE:UNH).
The Bull Market Report recently lowered its rating on one healthcare related stock and removed another from its Recommended List. In the consumer staples space, The Bull Market Report's Recommended List remains overweight in the healthcare space.
All paid and trial The Bull Market Report subscribers can now receive immediate access to The Bull Market Report's exclusive daily reports. As a trial or paid subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today: https://www.bullmarket.com/subscribe/?refer=BMR2
The Bull Market Report's investment outlook examines a number of issues, including:
-- The long-term impact of Pfizer's FDA application for the
inhalable insulin drug Exubera.
-- Sunrise Senior Living's fourth quarter results and 2005
guidance, and how new facility construction will impact the
company moving forward.
-- Analysis of and takeaways from the Medicare Drug Benefit plan.
-- Why a big run in one healthcare stock caused Bull Market Report
to lower its Recommended List rating.
-- Why UnitedHealth Group may be outperformed by its peers.
AND MORE!
Sign up now for a 14-day free trial to The Bull Market and you'll gain instant access to The Bull Market Report's in depth coverage of the financial services, healthcare, energy, technology and retail, among other, sectors, as well as our Recommended List of over 50 companies, by clicking here: https://www.bullmarket.com/subscribe/?refer=BMR2
Subscribers also receive access to The Bull Market Report's special bonus report, "Biotech Sector Outlook."
The Bull Market Report is perfect for investors who are serious about building a diversified investment portfolio and committed to creating long-term wealth.
About The Bull Market Report:
Launched in 1997, The Bull Market Report has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The newsletter is ideal for investors looking for long-term growth and income-generating stock investments.
The Bull Market Report's Recommended List includes over 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, Retail, among others. As a testament to the durability of its value-focused and fundamentally sound recommendations in both up and down markets, The Bull Market Report is one of the oldest continuously published investment newsletters online. For more information or to sign up now for a free 14-day trial to The Bull Market Report, please visit: https://www.bullmarket.com/subscribe/?refer=BMR2
Note: Indie Research, LLC and the Bull Market editorial staff are not registered investment advisors, broker/dealers, or research analysts/organizations.